TITLE

Liver transplantation in metabolic disorders: summary of the general discussion

AUTHOR(S)
Burdelski, M.; Ullrich, K.
PUB. DATE
December 1999
SOURCE
European Journal of Pediatrics;1999, Vol. 158 Issue 14, pS095
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a summary of discussion about liver transplantation in metabolic disorders. Antitrypsin deficiency; Neonatal haemochromatosis; Methylmalenic acidaemia.
ACCESSION #
4681732

 

Related Articles

  • Liver transplantation in maple syrup urine disease. Wendel, U.; Saudubray, J. M.; Bodner, A.; Schadewaldt, P. // European Journal of Pediatrics;1999, Vol. 158 Issue 14, pS060 

    Abstract Maple syrup urine disease (MSUD) is an autosomal recessive disorder. Impaired activity of the branched-chain 2-oxoacid dehydrogenase complex (BCOA-DH) causes accumulation of branched-chain L-amino (BCAA) and 2-oxoacids (BCOA) which may exert neurotoxic effects. Treatment comprises...

  • Preface. Burdelski, M.; Ullrich, K. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS33 

    Presents a preface on the international symposium on "Indication for Liver Transplantation in Metabolic Disorders" held in November 1997 in Fulda, Germany. Presence of experts in the field of transplantation and metabolic disorders from all over Europe and the U.S.; Inclusion of the reviews...

  • Ex Vivo Liver--Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors. Tuan Huy Nguyen; Mainot, Sylvie; Lainas, Panagiotis; Groyer-Picard, Marie-Th�r�se; Franco, Dominique; Dagher, Ibrahim; Weber, Anne // Current Gene Therapy;Apr2009, Vol. 9 Issue 2, p136 

    Transplantation of hepatocytes, whether genetically modified or not, has become an alternative to orthotopic liver transplantation for the treatment of patients with metabolic disease. However, more than ten years after the first clinical trial of ex vivo gene therapy to treat patients with...

  • Pediatric liver transplantation in India: Its time has come. D'Cruz, Ashley L. J. // Journal of Indian Association of Pediatric Surgeons;Jan-Mar2011, Vol. 16 Issue 1, p1 

    The author reflects on the practice of pediatric liver transplantation for end-stage liver disease (ESLD) treatment in India. She says that pediatric liver transplants in India was first performed in 1998 wherein most of the centers use live donor transplants. She adds that in India, 280 ESLD...

  • Hereditary and acquired amyloid neuropathies. Adams, David // Journal of Neurology;Aug2001, Vol. 248 Issue 8, p647 

    Amyloid neuropathies occur in a context of hereditary (FAP) or acquired amyloidosis. They present usually as severe and progressive polyneuropathy and carry a poor prognosis. Most FAP are associated with endoneurial deposits of variant transthyretin (TTR) with substitution of one aminoacid and...

  • Liver transplantation in urea cycle disorders. Saudubray, J. M.; Touati, G.; Delonlay, P.; Jouvet, P.; Narcy, C.; Laurent, J.; Rabier, D.; Kamoun, P.; Jan, D.; Revillon, Y. // European Journal of Pediatrics;1999, Vol. 158 Issue 14, pS055 

    Abstract We report here our experience in the long-term management of 28 patients with citrullinaemia, 13 patients with carbamoyl phosphate synthase deficiency and 15 patients with argininosuccinic aciduria. In addition, we report a national French survey of 119 patients with ornithine...

  • Liver transplantation in maple syrup urine disease. Wendel, U.; Bodner, A.; Saudubray, J. M.; Schadewaldt, P. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS60 

    Maple syrup urine disease (MSUD) is an autosomal recessive disorder. Impaired activity of the branched-chain 2-oxoacid dehydrogenase complex (BCOA-DH) causes accumulation of branched-chain L-amino (BCAA) and 2-oxoacids (BCOA) which may exert neurotoxic effects. Treatment comprises dietary...

  • Liver transplantation in metabolic disorders: summary of the general discussion. Burdelski, M.; Ullrich, K. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS95 

    Presents a summary of a general discussion on liver transplantation in the metabolic disorders. Results indicating performance of pre-emptive liver transplantation before the age of 6 years; Reduction of ca. 50% in plasma LDL-cholesterol concentrations due to liver transplantation;...

  • Liver transplantation in urea cycle disorders. Saudubray, J. M.; Touati, G.; Delonlay, P.; Jouvet, P.; Narcy, C.; Laurent, J.; Kamoun, P.; Rabier, D.; Jan, D.; Revillon, Y. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS55 

    We report here our experience in the long-term management of 28 patients with citrullinaemia, 13 patients with carbamoyl phosphate synthase deficiency and 15 patients with argininosuccinic aciduria. In addition, we report a national French survey of 119 patients with ornithine transcarbamylase...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics